Tempest Therapeutics (TPST) Competitor Comparison
We are evaluating the key criteria listed to compare Tempest Therapeutics (TPST) against its competitors in the Biotechnology industry.
Market Capitalization
274 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
109 / 337Free Cashflow
127 / 352Quick Ratio
307 / 357Earnings per Share
170 / 359Dividend yield
0 / 6Total Cash
321 / 358Performance 3 years
320 / 368Performance 5 years
358 / 368Performance 10 years
361 / 368Linearity 3 years
281 / 368Linearity 5 years
303 / 368Linearity 10 years
232 / 368Total Rank
276 / 368Dividend Rank
284 / 368Valuation Rank
237 / 368Piotroski Rank
235 / 368Muliplier Rank
60 / 368Free Cashflow - TPST ranking 127 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.